Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanomaKomel, Tilen (Avtor) Omerzel, Maša (Avtor) Kranjc Brezar, Simona (Avtor) De Robertis, Mariangela (Avtor) Mastrodonato, M. (Avtor) Scillitani, G. (Avtor) Pesole, Graziano (Avtor) Signori, Emanuella (Avtor) Serša, Gregor (Avtor) Čemažar, Maja (Avtor) gene therapygene electrotransferIL-12immunotherapymelanomaGene therapy has become an important approach for treating cancer, and electroporation represents a technology for introducing therapeutic genes into a cell. An example of cancer gene therapy relying on gene electrotransfer is the use of immunomodulatory cytokines, such as interleukin 2 (IL-2) and 12 (IL-12), which directly stimulate immune cells at the tumour site. The aim of our study was to determine the effects of gene electrotransfer with two plasmids encoding IL-2 and IL-12 in vitro and in vivo. Two different pulse protocols, known as EP1 (600 V/cm, 5 ms, 1 Hz, 8 pulses) and EP2 (1300 V/cm, 100 %s, 1 Hz, 8 pulses), were assessed in vitro for application in subsequent in vivo experiments. In the in vivo experiment, gene electrotransfer of pIL-2 and pIL-12 using the EP1 protocol was performed in B16.F10 murine melanoma. Combined treatment of tumours using pIL2 and pIL12 induced significant tumour growth delay and 71% complete tumour regression. Furthermore, in tumours coexpressing IL-2 and IL-12, increased accumulation of dendritic cells and M1 macrophages was obtained along with the activation of proinflammatory signals, resulting in CD4 + and CD8 + T-lymphocyte recruitment and immune memory development in the mice. In conclusion, we demonstrated high antitumour efficacy of combined IL-2 and IL-12 gene electrotransfer protocols in low-immunogenicity murine B16.F10 melanoma.Elsevier20212022-09-23 03:34:22Neznano15583UDK: 602.6/.7ISSN pri članku: 1567-5394DOI: 10.1016/j.bioelechem.2021.107843COBISS_ID: 67179011slby Authors